These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24992975)

  • 1. [Specialized histopathological second opinion of advanced ovarian cancer. Experiences with collectives from prospective randomized phase III studies].
    Kommoss S; Pfisterer J; du Bois A; Schmidt D; Kommoss F
    Pathologe; 2014 Jul; 35(4):355-60. PubMed ID: 24992975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specialized pathology review in patients with ovarian cancer: results from a prospective study.
    Kommoss S; Pfisterer J; Reuss A; Diebold J; Hauptmann S; Schmidt C; du Bois A; Schmidt D; Kommoss F
    Int J Gynecol Cancer; 2013 Oct; 23(8):1376-82. PubMed ID: 24257551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Central pathology review. Inclusion criterion for clinical studies of ovarian carcinomas?].
    Kommoss F; Kommoss S; Schmidt D; du Bois A; Pfisterer J
    Pathologe; 2008 Nov; 29 Suppl 2():157-9. PubMed ID: 18726596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Better resource utilisation and quality of care for ovarian cancer patients using internet-based pathology review.
    Kommoss S; Kommoss F; Diebold J; Lax S; Schmidt D; Staebler A; du Bois A; Pfisterer J
    Br J Cancer; 2017 Jan; 116(3):287-292. PubMed ID: 28006819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second Opinion Expert Pathology in Endometrial Cancer: Potential Clinical Implications.
    Grevenkamp F; Kommoss F; Kommoss F; Lax S; Fend F; Wallwiener D; Schönfisch B; Krämer B; Brucker SY; Taran FA; Staebler A; Kommoss S
    Int J Gynecol Cancer; 2017 Feb; 27(2):289-296. PubMed ID: 27922981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG).
    Henno S; Jeanne C; Rouge TM; Genestie C; Treilleux I; Croce S; Just PA; Le Frere-Belda MA; Guinaudeau E; Penault-Llorca F; Arnould L; Mery-Lamarche E; Leroux A; Lemaire AS; Averous G; Renaud O; Charafe-Jauffret E; Bonneau C; Leaha C; Ray-Coquard I; Devouassoux-Shisheboran M
    Gynecol Oncol; 2022 Jun; 165(3):637-641. PubMed ID: 35393217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials.
    George A; Kristeleit R; Rafii S; Michie CO; Bowen R; Michalarea V; van Hagen T; Wong M; Rallis G; Molife LR; Lopez J; Banerji U; Banerjee SN; Gore ME; de Bono JS; Kaye SB; Yap TA
    Eur J Cancer; 2017 May; 76():52-59. PubMed ID: 28273485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Surgical Staging in Stage 1 Clear Cell and Endometrioid Ovarian Carcinomas: Is it Necessary?
    Padhy RR; Savage J; Kurman RJ
    Int J Gynecol Pathol; 2019 May; 38(3):241-246. PubMed ID: 29750701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of Endometrioid and Clear Cell Carcinoma of the Ovary.
    Fadare O; Parkash V
    Surg Pathol Clin; 2019 Jun; 12(2):529-564. PubMed ID: 31097114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
    Dizon DS; Restivo A; Lomme M; Charbonneau N; Brard L; Hughes T; Weitzen S; Legare R; Granai CO; Disilvestro P
    Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
    McCluggage WG
    Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
    Chew S; Tham KF; Ratnam SS
    Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
    Cuff J; Longacre TA
    Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frozen Section Diagnosis of Ovarian Epithelial Tumors: Diagnostic Pearls and Pitfalls.
    Buza N
    Arch Pathol Lab Med; 2019 Jan; 143(1):47-64. PubMed ID: 30785337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative assessment of clear cell carcinoma of the ovary.
    Stewart CJ; Brennan BA; Hammond IG; Leung YC; McCartney AJ; Ruba S
    Int J Gynecol Pathol; 2008 Oct; 27(4):475-82. PubMed ID: 18753976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary tumor types and origins in positive abdominopelvic washing cytology, a single institution experience.
    Hou Y; Bruehl FK; McHugh KE; Reynolds JP
    J Am Soc Cytopathol; 2020; 9(2):89-94. PubMed ID: 31734259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study.
    Zaino RJ; Brady MF; Lele SM; Michael H; Greer B; Bookman MA
    Cancer; 2011 Feb; 117(3):554-62. PubMed ID: 20862744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers.
    Ceppi L; Grassi T; Galli F; Buda A; Aletti G; Lissoni AA; Adorni M; Garbi A; Colombo N; Bonazzi C; Landoni F; Fruscio R
    Gynecol Oncol; 2021 Jan; 160(1):64-70. PubMed ID: 33077259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current status of surgical staging of ovarian serous borderline tumors.
    Lin PS; Gershenson DM; Bevers MW; Lucas KR; Burke TW; Silva EG
    Cancer; 1999 Feb; 85(4):905-11. PubMed ID: 10091769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.